Client News

Posted: March 1, 2017, 6:04 pm
Posted: March 1, 2017, 6:04 pm
[Accesswire] - Developing Oral Recombinant Products to address Gastrointestinal Diseases and Microbiome Related Conditions; Report Available here: NEW YORK, NY / ...
Posted: March 1, 2017, 4:18 pm
[Business Wire] - The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Alcobra, Ltd.
Posted: March 1, 2017, 2:00 pm
[PR Newswire] - INDIANAPOLIS, March 1, 2017 /PRNewswire/ -- Eli Lilly and Company (LLY) today announced the successful completion of its acquisition of CoLucid Pharmaceuticals, Inc. (CLCD). The tender offer for all outstanding shares of common stock of CoLucid, at a price of $46.50 per share, expired as scheduled on Tuesday, February 28, 2017. As of the expiration of the tender offer, 17,410,607 shares of CoLucid common stock were validly tendered, representing approximately 90.3 percent of the shares outstanding, and have been accepted for payment under the terms of the tender offer.
Posted: March 1, 2017, 1:45 pm
[GlobeNewswire] - BOSTON, March 01, 2017-- Albireo Pharma, Inc., a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President and Chief Executive ...
Posted: March 1, 2017, 1:00 pm
[GlobeNewswire] - EMERYVILLE, Calif., March 01, 2017-- Zogenix, Inc., a pharmaceutical company developing therapies for the treatment of orphan and central nervous system disorders, today announced that the European Commission ...
Posted: March 1, 2017, 1:00 pm
[Business Wire] - Aimmune Therapeutics, Inc. , a biopharmaceutical company developing CODIT™ treatments for life-threatening food allergies, today announced that CEO Stephen Dilly, M.B.B.S., Ph.D., will present a company overview at the Cowen and Company 37th Annual Health Care Conference on Wednesday, March 8, 2017, at 10:00 a.m.
Posted: March 1, 2017, 1:00 pm
[GlobeNewswire] - TEL AVIV, Israel, March 01, 2017-- Alcobra Ltd., an emerging pharmaceutical company focused on the development of new medications to treat central nervous system and cognitive disorders, today announced ...
Posted: March 1, 2017, 1:00 pm
[PR Newswire] - HACKENSACK, N.J. and PETACH TIKVAH, Israel, March 1, 2017 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, ...
Posted: March 1, 2017, 11:45 am
Posted: March 1, 2017, 11:17 am
[GlobeNewswire] - TiGenix to present at Cowen's 37th Annual Health Care Conference in Boston. Leuven- 1 st March, 2017, 07:00 h CET- TiGenix NV, an advanced biopharmaceutical company focused on developing and commercializing ...
Posted: March 1, 2017, 6:01 am